COMMUNIQUÉS West-GlobeNewswire

-
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
04/06/2024 -
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
04/06/2024 -
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
04/06/2024 -
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
04/06/2024 -
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
04/06/2024 -
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
04/06/2024 -
XORTX to Present at BIO International Convention 2024
04/06/2024 -
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
04/06/2024 -
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
04/06/2024 -
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress
04/06/2024 -
Bitterroot Bio Announces Appointment of Georgette Verdin as Chief People Officer and Sherwin Chen as Chief Legal Officer and Corporate Secretary
04/06/2024 -
American Oncology Network Announces the Research Studies Presented at the ASCO 2024 Annual Meeting
04/06/2024 -
STRATA Skin Sciences to Participate in June Dermatology Conferences
04/06/2024 -
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
04/06/2024 -
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
04/06/2024 -
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
04/06/2024 -
The MUHC Foundation’s Le Bal Rouge Gala Raises a record-breaking $2,050,000 million for Cancer Research at the MUHC
04/06/2024 -
Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2,050,000 $ pour la recherche sur le cancer au CUSM
04/06/2024 -
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
04/06/2024
Pages